EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural Chiral Scaffolds in Alzheimer′s Disease: Therapeutic Potential, Mechanism, and Clinical Aspects

Aniket Singh iD, Sanjeev Kumar Sahu iD, Anil Kumar Sah iD

BioMed Research International · 2026

DOI: 10.1155/bmri/5968529 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioMed Research International, 2026. Verfasst von Aniket Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India, lpu.in. Hauptthemen laut MEDLINE: Alzheimer Disease, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer′s disease (AD) is a multifactorial neurodegenerative disorder characterized by progressive cognitive impairment, amyloid‐ β deposition, tau pathology, oxidative stress, neuroinflammation, and dysfunction of synapses. Current therapeutic options are largely symptomatic and lack disease‐modifying efficacy. Target binding, pharmacokinetics, and therapeutic efficacy in AD are all significantly impacted by the stereochemistry of many bioactive natural scaffolds, which are enantiomerically defined molecules. Due to the complexity of their stereochemical structures and their multiple‐target pharmacological attributes, natural chiral scaffolds have received significant attention as lead compounds to treat AD. The chirality has a critical impact on target selectivity, receptor binding, blood–brain barrier permeability, and pharmacokinetic behavior. By combining stereochemistry with pharmacological and clinical data, it is possible to expedite the discovery of safer and more effective disease‐modifying therapies, thus making chiral natural products attractive for AD drug discovery in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiological ProductsHumansStereoisomerismAnimalsBlood-Brain BarrierAmyloid beta-PeptidesDrug Discovery

Stichwörter der Autor:innen

Alzheimer′s diseasechiral compoundsclinical aspectsnatural productphytoconstituenttherapeutic

Substanzen

Biological ProductsAmyloid beta-Peptides

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India, lpu.in.
  • Division of Quality Control, Gorkha Ayurved Company Pvt. Ltd., Gorkha Haramtari, Kathmandu, Nepal.

ORCID-Profile: Aniket Singh, Sanjeev Kumar Sahu, Anil Kumar Sah

Zitieren

APA

Singh, A., Sahu, S. K., & Sah, A. K. (2026). Natural Chiral Scaffolds in Alzheimer′s Disease: Therapeutic Potential, Mechanism, and Clinical Aspects. BioMed Research International. https://doi.org/10.1155/bmri/5968529

Vancouver

Singh A, Sahu SK, Sah AK. Natural Chiral Scaffolds in Alzheimer′s Disease: Therapeutic Potential, Mechanism, and Clinical Aspects. BioMed Research International. 2026. doi:10.1155/bmri/5968529

BibTeX
@article{Singh2026,
  author = {Singh, Aniket and Sahu, Sanjeev Kumar and Sah, Anil Kumar},
  title = {Natural Chiral Scaffolds in Alzheimer′s Disease: Therapeutic Potential, Mechanism, and Clinical Aspects},
  journal = {BioMed Research International},
  year = {2026},
  doi = {10.1155/bmri/5968529}
}
Kostenlos starten →